Documents uploaded to the U.S. Department of Justice (DoJ) Foreign Agents Registration Act (FARA) eFile system don't just ...

A research team led by Prof. TAN Weihong and Prof. WU Qin from the Hangzhou Institute of Medicine (HIM) of the Chinese Academy of Sciences has developed a pioneering, multi-modal platform called SPARK ...

Cell-surface proteins are critical therapeutic targets and are vital to cellular communication, signaling, and homeostasis. However, developing high-affinity probes such as aptamers against these ...

Notably, the paper also includes simulation studies outlining when dDRTC is most effective, positioning it as a practical ...

Hydrogen fuel cells are widely recognized as a clean and high-efficiency alternative to fossil energy, but commercial ...

A combination of molecular dynamics simulation and state-of-the-art statistical post-processing techniques provided valuable insight into GPCR-ligand dynamics. This manuscript provides solid evidence ...

Drug discovery is a complex field that demands rigorous testing and comprehensive data analysis to ensure potential drug candidates can advance to clinical trials. One critical step is screening for ...

Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through single-molecule detection, announces a new preprint ...

Researchers at ESPCI Paris and Quantum-Si demonstrate scalable platform for parallel binding kinetics and sequencing in new preprint Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the ...

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining ...

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and ...